Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
SPI Pharma
16 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Modified-Release Drug Formulations
Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores
PAO-05-23-CL-06
Taste Masking Formulations
Formulating Flexibility with ActiMask® Taste Masking
PAO-10-022-CL-05
Formulation
Incorporating Patient Voices from the Start of Drug Development
PAO-01-22-R250-10
ODT
Introducing UltraBurst, the Fastest Rapidly Disintegrating Product
PTV-08-21-CL-001
Orally Disintegrating Tablets
A Revolutionary Excipient Platform for Super-Fast Disintegrating ODTs
PAO-07-21-CL-03
Launch
SPI Pharma Launches UltraBurst™, the First In Class Preformulated Platform for Flash Orally Dispersible Tablets
PR-M07-21-03
The Future of Healthcare
How Does SPI Pharma Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-009
Leadership
SPI Pharma Appoints Scott Thomson as CEO
PR-M10-20-08
The Future of Healthcare
How Is SPI Pharma Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-004
The Future of Healthcare
How is SPI Pharma Innovating through the Pandemic and Beyond to Define the Future of Healthcare?
PAP-Q2-20-RT2-007
Excipients
New Mannitol Formulations Are a Gem of a Collection
PAP-Q1-20-CL-004
The Future of Healthcare
How is SPI Pharma Preparing to Face the Future of Healthcare?
PAP-Q1-20-R2-008
Virtual Panel
Reprioritizing to Bring FY2020 into Focus
PAP-Q1-2019-CL-032
Orally Disintegrating Tablets
Creating Value with Tailored ODT Solutions
PAP-Q3-18-CL-011
Formulation
Investing in New Technologies for Innovative Functional Solutions
PAP-Q1-18-CL-009
Focusing on Patient Compliance
PTV-M01-17-NS-011
.svg)
